Anthropic is bringing Voice Mode to Claude Code, the company’s AI coding assistant for developers. The launch of voice mode marks a significant step toward more hands-free, conversational coding ...

Have you ever wondered about the string of letters after the name of the tomato variety? You will see these letters often on tomato plant labels or seed packets. Some varieties will have them, and ...

The potential future space for Code Ninjas in the Lee Harrison Shopping Center (staff photo by Jared Serre) A kid-focused coding academy is in the works at the Lee Harrison Shopping Center, and it’s ...

Anthropic opened its virtual "Briefing: Enterprise Agents" event on Tuesday with a provocation. Kate Jensen, the company's head of Americas, told viewers that the hype around enterprise AI agents in ...

Feb 23 (Reuters) - Shares of International Business Machines (IBM.N), opens new tab recorded their steepest daily drop in more than 25 years on Monday, after AI startup Anthropic said its Claude Code ...

International Business Machines stock is getting slammed Monday, becoming the latest perceived victim of rapidly developing AI technology, after Anthropic said its Claude Code tool could be used to ...

LOUISVILLE, Ky. — Code Louisville, a free tech training program that has prepared an estimated 5,000 Kentuckians for careers in software development over the past 13 years, will teach its final class ...

ROCHESTER, N.Y. — Temperatures are in the teens on Tuesday morning in the Rochester area, but feel like they’re in the single digits with the wind chill. With the frigid temperatures, shelter leaders ...

Tel Aviv, Israel, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), an advanced technologies company, today ...

Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling CareDx will ...

Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling CareDx, Inc.